1. Polycyclodextrin as a linker for nanomedicine fabrication and synergistic anticancer application.
- Author
-
Wang D, Mu X, Chen X, Huang H, Zhou L, and Wei S
- Subjects
- Adamantane radiation effects, Adamantane therapeutic use, Animals, Cyclodextrins toxicity, Female, Ferrocyanides chemistry, Ferrocyanides toxicity, HeLa Cells, Humans, Isoindoles radiation effects, Isoindoles therapeutic use, Light, Mice, Inbred BALB C, Nanomedicine methods, Nanoparticles toxicity, Neoplasms metabolism, Organometallic Compounds radiation effects, Organometallic Compounds therapeutic use, Photosensitizing Agents radiation effects, Polymers toxicity, Reactive Oxygen Species metabolism, Ytterbium chemistry, Ytterbium toxicity, Zinc Compounds radiation effects, Zinc Compounds therapeutic use, Mice, Antineoplastic Agents therapeutic use, Cyclodextrins chemistry, Nanoparticles chemistry, Neoplasms drug therapy, Photosensitizing Agents therapeutic use, Polymers chemistry
- Abstract
Polycyclodextrin (denoted PCD) composed of cyclodextrin monomer units and 1,3-diethoxypropan-2-ol containing many hydroxyl groups with lone pairs of electrons, easily coordinated with transition metals with empty orbitals. The CD unit can also provide host-guest binding sites for functional molecules. This article utilizes this feature of PCD for the first time as a "linker" to combine transition metal nanomaterials with synergistic functional molecules. We synthesized PCD with 50% CD monomer by epichlorohydrin cross-linking method. Utilizing the coordination effect of the hydroxyl group in PCD and the iron ion in photothermal nanoparticles (PB-Yb), the PCD is coated on its surface; simultaneously, CD in PCD can form a host-guest complex with adamantane-modified zinc phthalocyanine (Pc) photosensitizer. Using PCD as a "linker", PB-Yb and Pc (denoted PYPP) were combined to improve the solubility of PB-Yb, reduce the aggregation degree of Pc to increase their activity, and achieve photothermal and photodynamic synergistic tumor therapy., (Copyright © 2021. Published by Elsevier Ltd.)
- Published
- 2021
- Full Text
- View/download PDF